EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Efficacy and Safety of Sulforaphane Added to Antipsychotics for the Treatment of Negative Symptoms of Schizophrenia

Jing Huang, AnMei Chen, Hua Jin, Fangkun Liu, Gangrui Hei, Ziwei Teng, Jingmei Xiao, Renrong Wu, Jingping Zhao, John M Davis, Ping Shao, Robert C Smith

The Journal of Clinical Psychiatry · 2025

DOI: 10.4088/jcp.24m15272 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Clinical Psychiatry, 2025. Verfasst von Jing Huang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, and National Clinical Research Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changs…. Hauptthemen laut MEDLINE: Schizophrenia, Isothiocyanates, Antipsychotic Agents, Sulfoxides. Die Arbeit wurde bisher 18-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SchizophreniaIsothiocyanatesAntipsychotic AgentsSulfoxidesHumansMaleFemaleAdultDouble-Blind MethodDrug Therapy, CombinationMiddle AgedTreatment Outcome

Substanzen

sulforaphaneIsothiocyanatesAntipsychotic AgentsSulfoxides

Autor:innen und Institutionen

  • Department of Psychiatry, and National Clinical Research Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, P. R. China.
  • Columbia University Mailman School of Public Health, New York, New York.
  • Department of Psychiatry, University of California San Diego and Psychiatric Service, VA San Diego Healthcare System, San Diego, California.
  • Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, P. R. China.
  • Department of Psychiatry, The First Affiliated Hospital of Zhengzhou University, Henan, China.
  • Department of Psychiatry, University of Illinois, Chicago, Illinois.

Zitieren

APA

Huang, J., Chen, A., Jin, H., Liu, F., Hei, G., Teng, Z., Xiao, J., Wu, R., Zhao, J., Davis, J. M., Shao, P., & Smith, R. C. (2025). Efficacy and Safety of Sulforaphane Added to Antipsychotics for the Treatment of Negative Symptoms of Schizophrenia. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.24m15272

Vancouver

Huang J, Chen A, Jin H, Liu F, Hei G, Teng Z, et al. Efficacy and Safety of Sulforaphane Added to Antipsychotics for the Treatment of Negative Symptoms of Schizophrenia. The Journal of Clinical Psychiatry. 2025. doi:10.4088/jcp.24m15272

BibTeX
@article{Huang2025,
  author = {Huang, Jing and Chen, AnMei and Jin, Hua and Liu, Fangkun and Hei, Gangrui and Teng, Ziwei and Xiao, Jingmei and Wu, Renrong and Zhao, Jingping and Davis, John M and Shao, Ping and Smith, Robert C},
  title = {Efficacy and Safety of Sulforaphane Added to Antipsychotics for the Treatment of Negative Symptoms of Schizophrenia},
  journal = {The Journal of Clinical Psychiatry},
  year = {2025},
  doi = {10.4088/jcp.24m15272}
}
Kostenlos starten →